Philippa Whitford Portrait

Philippa Whitford

Scottish National Party - Central Ayrshire

Shadow SNP Spokesperson (Health and Social Care)

(since June 2017)

Shadow SNP Spokesperson (Europe)

(since February 2020)
Committee on the Future Relationship with the European Union
2nd Mar 2020 - 16th Jan 2021
Shadow SNP Spokesperson (Exiting the European Union)
7th Jan 2020 - 31st Jan 2020
European Scrutiny Committee
30th Oct 2017 - 6th Nov 2019
Health and Social Care Committee
14th Jan 2019 - 13th May 2019
Draft Domestic Abuse Bill (Joint)
27th Feb 2019 - 6th Mar 2019
Draft Health Service Safety Investigation Bill (Joint Committee)
17th Apr 2018 - 27th Jul 2018
Shadow SNP Westminster Group Leader (Health)
20th May 2015 - 20th Jun 2017
Health and Social Care Committee
8th Jul 2015 - 3rd May 2017


Department Event
Monday 28th June 2021
Department of Health and Social Care
Legislation - Main Chamber
The Rating (Coronavirus) and Directors Disqualification (Dissolved Companies) Bill: Second Reading
View calendar
Note: This event involves a Department with which this person is linked, and does not guarantee their actual attendance.
Division Votes
Monday 7th June 2021
Advanced Research and Invention Agency Bill
voted Aye - in line with the party majority
One of 42 Scottish National Party Aye votes vs 0 Scottish National Party No votes
Tally: Ayes - 263 Noes - 364
Speeches
Monday 21st June 2021
Oral Answers to Questions

The UKRI’s global challenges research fund was set up to promote international collaboration on global issues, including climate change and …

Written Answers
Monday 7th June 2021
Coronavirus: Vaccination
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of whether clinically …
Early Day Motions
Wednesday 2nd September 2020
Protecting and valuing whistleblowers
That this House recognises that the Public Interest Disclosure Act (1998) does not provide a sufficient degree of protection for …
Bills
Wednesday 5th February 2020
Public Interest Disclosure (Protection) Bill 2019-21
A Bill to provide protections for whistleblowers; to create offences relating to the treatment of whistleblowers and the handling of …
MP Financial Interests
Tuesday 1st September 2020
1. Employment and earnings
29 July 2020, received final payment of £1,815.68. Hours: 69.5 hrs. (Registered 26 August 2020)
EDM signed
Monday 21st June 2021
Protests in Colombia
That this House expresses profound concern on reports of excessive use of force by the Colombian police, against overwhelmingly peaceful …
Supported Legislation
Tuesday 24th March 2020
Wellbeing of Future Generations (No. 2) Bill 2019-21
A Bill to make provision for requiring public bodies to act in pursuit of the United Kingdom’s environmental, social, economic …

Division Voting information

During the current Parliamentary Session, Philippa Whitford has voted in 211 divisions, and never against the majority of their Party.
View All Philippa Whitford Division Votes

Debates during the 2019 Parliament

Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.

View all Philippa Whitford's debates

Central Ayrshire Petitions

e-Petitions are administered by Parliament and allow members of the public to express support for a particular issue.

If an e-petition reaches 10,000 signatures the Government will issue a written response.

If an e-petition reaches 100,000 signatures the petition becomes eligible for a Parliamentary debate (usually Monday 4.30pm in Westminster Hall).

Petitions with highest Central Ayrshire signature proportion
Petitions with most Central Ayrshire signatures
Philippa Whitford has not participated in any petition debates

Latest EDMs signed by Philippa Whitford

11th May 2021
Philippa Whitford signed this EDM on Monday 21st June 2021

Protests in Colombia

Tabled by: Tony Lloyd (Labour - Rochdale)
That this House expresses profound concern on reports of excessive use of force by the Colombian police, against overwhelmingly peaceful social protests as confirmed by the UN Office of the High Commissioner for Human Rights across Colombia from 28 April 2021, as part of a national strike; believes the right …
89 signatures
(Most recent: 21 Jun 2021)
Signatures by party:
Labour: 39
Scottish National Party: 28
Liberal Democrat: 8
Independent: 4
Democratic Unionist Party: 3
Plaid Cymru: 3
Social Democratic & Labour Party: 2
Alba Party: 2
Green Party: 1
Alliance: 1
15th June 2021
Philippa Whitford signed this EDM on Thursday 17th June 2021

Australian trade deal

Tabled by: Tim Farron (Liberal Democrat - Westmorland and Lonsdale)
That this House notes the prospective agreement of a trade deal with Australia; expresses strong concern at the potential implications of any deal on British farmers; asks that farmers across the country are properly consulted; further asks that MPs are given the time to adequately read, scrutinise and debate the …
25 signatures
(Most recent: 21 Jun 2021)
Signatures by party:
Liberal Democrat: 9
Labour: 4
Scottish National Party: 4
Plaid Cymru: 3
Independent: 1
Alba Party: 1
Democratic Unionist Party: 1
Green Party: 1
Social Democratic & Labour Party: 1
Alliance: 1
View All Philippa Whitford's signed Early Day Motions

Commons initiatives

These initiatives were driven by Philippa Whitford, and are more likely to reflect personal policy preferences.

MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.


Philippa Whitford has not been granted any Urgent Questions

Philippa Whitford has not been granted any Adjournment Debates

2 Bills introduced by Philippa Whitford


A Bill to provide protections for whistleblowers; to create offences relating to the treatment of whistleblowers and the handling of whistleblowing cases; to establish an independent body to protect whistleblowers and whistleblowing, in accordance with the public interest; to make provision for that body to set, monitor and enforce standards for the management of whistleblowing cases, to provide disclosure and advice services, to direct whistleblowing investigations and to order redress of detriment suffered by whistleblowers; to repeal the Public Interest Disclosure Act 1998; and for connected purposes.


Last Event - 2nd Reading (Commons)
Friday 25th September 2020
(Read Debate)

The Bill failed to complete its passage through Parliament before the end of the session. This means the Bill will make no further progress. A Bill to reform the Universal Credit application process; to make provision about advice and assistance for claimants, and arrangements for payments; and for connected purposes.


Last Event - 1st Reading: House Of Commons
Monday 27th November 2017
(Read Debate)

116 Written Questions in the current parliament

(View all written questions)
Written Questions can be tabled by MPs and Lords to request specific information information on the work, policy and activities of a Government Department
20th May 2021
To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, what assessment he has made of the immunological limits of covid-19 status certification.

The Government committed to explore whether and how COVID-status certification might be used to reopen our economy, reduce restrictions on social contact and improve safety. As set out in the ‘COVID-19 Response - Spring 2021,’ the Government will set out its conclusions on the COVID-status Certification Review in advance of Step 4 of the Roadmap, in order to inform the safe reopening of society and the economy.

An update on the Roadmap Reviews was published on 5 April and can be found here:

https://www.gov.uk/government/publications/covid-19-response-spring-2021-reviews-terms-of-reference/roadmap-reviews-update.

Penny Mordaunt
Paymaster General
14th Apr 2021
To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, what steps the Government is taking to ensure that the Taskforce on Innovation, Growth and Regulatory Reform is able to promote innovation in the development of cancer medicines.

I refer the hon. Member to the answer given to PQ174869 on 13 April 2021.

Julia Lopez
Parliamentary Secretary (Cabinet Office)
24th Mar 2021
To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, what steps the Government is taking to ensure that the Taskforce on Innovation, Growth and Regulatory Reform promotes innovation in the development of cancer medicines.

The Terms of Reference for the Taskforce have been published on GOV.UK. As set out there, the Taskforce has been commissioned by the Prime Minister to consider opportunities for regulatory reform across the economy independently, and to report to him in April. It is a matter for the Taskforce to decide its areas of focus within the Terms of Reference.

Penny Mordaunt
Paymaster General
24th Mar 2021
To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, what plans the Government has to involve medical research charities with the Taskforce on Innovation, Growth and Regulatory Reform.

The Terms of Reference for the Taskforce have been published on GOV.UK. As set out there, the Taskforce has been commissioned by the Prime Minister to consider opportunities for regulatory reform across the economy independently, and to report to him in April. It is a matter for the Taskforce to decide its areas of focus within the Terms of Reference.

Penny Mordaunt
Paymaster General
25th Jan 2021
To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, how many local authorities will take part in pilot schemes of the audio voting device for blind and partially sighted voters at the next election.

The Government is committed to ensuring that elections are accessible for all those eligible to vote and has been working with the RNIB to improve the voting process for voters with sight loss. We are currently considering how best to implement changes better to support blind and partially sighted people to cast their vote. Announcements will be made in the usual way.

Julia Lopez
Parliamentary Secretary (Cabinet Office)
23rd Jun 2020
To ask the Minister for the Cabinet Office, what his response is to the call all for a six-month delay to checks in the Irish Sea in the document entitled: Implementing the Northern Ireland Protocol: What Business in Northern Ireland needs & why published by the NI Business Brexit Working Group.

The UK Government will continue to prepare to meet our obligations under the Northern Ireland Protocol, in line with the approach set out in the 20 May Command Paper, the UK’s Approach to the Northern Ireland Protocol. In this paper, we committed to providing guidance to business, including our plans for extensive HMRC support for Northern Ireland businesses engaging in any new processes under the Protocol. We will publish that guidance this summer.

We will also continue to engage with business through the Business Engagement Forum, which met for the first time on 10 June and which will play an important part in our thinking as we implement the Protocol.

Penny Mordaunt
Paymaster General
22nd Jun 2020
To ask the Minister for the Cabinet Office, what guidance his Department has issued to businesses on shipping goods (a) to and (b) from Northern Ireland to the rest of the UK in preparation for the end of the transition period.

The UK Government will meet its obligations under the Northern Ireland Protocol, in line with the approach set out in the Command Paper published on 20 May, the UK’s Approach to the Northern Ireland Protocol. We will ensure that the Protocol is implemented in a way that upholds the gains of the Belfast (Good Friday) Agreement, and which protects the interests of the people and economy of Northern Ireland. We committed in the UK’s Approach to the Northern Ireland Protocol to provide guidance to business, including our plans for extensive support for NI businesses engaging in new processes. We will publish that guidance during the course of this summer.

Penny Mordaunt
Paymaster General
22nd Jun 2020
To ask the Minister for the Cabinet Office, by what date the UK Government plans to have additional (a) staff and (b) infrastructure in place to comply with the Northern Ireland protocol in relation to checks on products moving between Northern Ireland and the rest of the UK.

The UK Government will meet its obligations under the Northern Ireland Protocol, in line with the approach set out in the Command Paper published on 20 May, the UK’s Approach to the Northern Ireland Protocol. We will ensure that the Protocol is implemented in a way that upholds the gains of the Belfast (Good Friday) Agreement, and which protects the interests of the people and economy of Northern Ireland. We committed in the UK’s Approach to the Northern Ireland Protocol to provide guidance to business, including our plans for extensive support for NI businesses engaging in new processes. We will publish that guidance during the course of this summer.

Penny Mordaunt
Paymaster General
9th Jun 2020
To ask the Minister for the Cabinet Office, what discussions has he had with business leaders in Northern Ireland who are calling for a six month delay to customs checks in the Irish Sea following the transition period.

Ministerial meetings with external organisations and individuals are declared quarterly on GOV.UK.

Penny Mordaunt
Paymaster General
22nd Mar 2021
To ask the Secretary of State for Business, Energy and Industrial Strategy, which sectors (a) his Department and (b) HM Treasury plan to consider in the development of Sector Visions as outlined in the Plan for Growth.

As set out in ‘Build Back Better: our plan for growth’, over the next 12 months the Government will work to develop visions for high growth sectors that will help shape the UK’s future and build on our existing competitive advantage and strengths in innovation. The specific sectors will be set out in the coming months.

Nadhim Zahawi
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
22nd Mar 2021
To ask the Secretary of State for Business, Energy and Industrial Strategy, how the UK manufacturing sector fits into the future of innovation in the (a) Plan for Growth and (b) upcoming Innovation Strategy.

The Government is, and will continue to be, a champion of the needs of business and industry, including the UK manufacturing sector. This is why Build Back Better: plan for growth and its supporting strategies will put the UK at the forefront of opportunities, give businesses the confidence to invest, boost productivity across the UK, enable our green industrial revolution, and support our vision for Global Britain.

As announced in the Plan for Growth, published alongside Budget, the Department is engaging across Government to develop an Innovation Strategy. As well as working across Whitehall and with our Innovation Expert Group, we want to engage with the innovation community, including the manufacturing sector which accounts for 64% of all business expenditure on UK R&D, to ensure the evidence base is sound and the policy proposals in the Strategy are well developed.

Nadhim Zahawi
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
12th Mar 2021
To ask the Secretary of State for Business, Energy and Industrial Strategy, what discussions he has had with the Secretary of State for Foreign, Commonwealth and Development Affairs on the maintenance of the science and research funding in the international aid budget.

My Rt. Hon. Friend the Foreign Secretary ran a cross-government process with Departments to review in detail how ODA is allocated between key priorities. The Foreign Secretary announced an ODA settlement of £706 million for my Department on Tuesday 26th January.

Though the impact of the COVID pandemic has impacted ODA budgets, international collaboration remains central to a healthy and productive R&D sector. The Government’s commitment to research and innovation has been clearly demonstrated, given we are increasing investment in R&D across government to £14.6bn in 2021/22, and as set out in our Integrated Review ambition.

Amanda Solloway
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
12th Mar 2021
To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the effect of the covid-19 outbreak on the level of demand on the UK Research and Innovation budget.

In contrast to the number of open calls that UKRI runs, which remained relatively stable with an additional surge to deliver specific COVID-19 related funding, the number of applications for funding from UKRI has risen over the last year, including in response to COVID-19. To date the trend has already shown an increase of over 1,000 applications ending December 2020, with a further projection of another 2,000 applications to be received in the final quarter. These increases are against an active portfolio of approximately 14,000 grants.

UKRI has also responded to increased demand to help stabilise the system and the pressures felt across the research and innovation community. Active grants continue to attract a high number of requested changes through their life, but more recently hundreds more enquiries have resulted from COVID-19 disruption, generating many requests for both costed and no cost extensions with £90 million in costed grant extensions paid this year.

Other stabilising interventions that UKRI has made in response to the pandemic include bringing forwards £100 million of Quality Related funding from Academic Year 2020-21 to AY 2019-20, and providing additional funding through the Sustaining University Research Expertise (SURE) Fund in financial year 2020-21.

Amanda Solloway
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
12th Mar 2021
To ask the Secretary of State for Business, Energy and Industrial Strategy, what plans his Department has to support the post-pandemic career development of early career researchers.

The Government invests in research talent through PhDs and fellowship schemes. UK Research and Innovation (UKRI) is the single biggest funder of PhDs in the UK and currently funds between six and seven thousand PhDs per year (around 53% in STEM) through its studentships and training grants, including Centres for Doctoral Training and Doctoral Training Partnerships.

Multi-year fellowship schemes funded by BEIS are delivered both by the National Academies and UKRI and are targeted at different career stages, from early career researchers to research professors and chairs. These schemes support the development and progression of a broad spectrum of researchers and their teams while supporting their excellent research.

The Department is currently working with UKRI on the development of an R&D People and Culture Strategy as one of my top priorities. The R&D People and Culture Strategy will look to ensure the UK has the people we need at all levels, working in a culture that gets the best out of everyone and delivers the best outcomes for the country.  A key part of this will be ensuring the R&D workforce has the capacity and capability to deliver the government’s ambitions for R&D with enough people with the right skills across disciplines, and throughout career stages and job roles.

Amanda Solloway
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
15th Dec 2020
To ask the Secretary of State for Business, Energy and Industrial Strategy, what plans the Government has to encourage the decommissioning of older aircraft.

The Government remains in dialogue with industry and overseas governments about the potential benefits, practicalities and implications of an aircraft scrappage scheme.

Paul Scully
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
26th Nov 2020
To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps he will take in response to the 2020 Spending Review to support the research undertaken by medical research charities.

The Government is aware of the challenges, caused by the COVID-19 pandemic, that medical research charities are currently facing.

The Government already provides significant funding to charities’ research, for example through Research England’s Quality Related (QR) charity support funding. This year charity QR will amount to £204m, to support charity funded research in universities in England and equivalent support is provided in Scotland through devolved funding arrangements.

Additionally, the Government supports this research through investments in the necessary infrastructure, through collaborations with UKRI and through the tax system. In 2018-19 over £1.3bn in tax relief on donations was received through Gift Aid benefitting all charities, including those carrying out vital medical research.

BEIS has been working with the Association of Medical Research Charities to develop an appropriate approach to supporting the important research that their members fund.

Amanda Solloway
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
11th Nov 2020
To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment his Department has made of the health benefits of bereavement leave.

The Government recognises that the death of a family member is deeply upsetting for those involved. The death of a child is particularly tragic, and this is why the Department for Business, Energy and Industrial Strategy we introduced Parental Bereavement Leave and Pay in April this year.

All employees have right to take a reasonable amount of time off work for an emergency involving a dependant, including in the case of bereavements. The entitlement could, for example, be used to make funeral and other arrangements.

We expect employers to respond with compassion and understanding in the case of all bereavements and we have given them the tools that they need to do this. In 2014 Acas published their guidance on Managing a Bereavement in the Workplace: A Good Practice Guide. This is available on the ACAS website- www.acas.org.uk.

Paul Scully
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
11th Nov 2020
To ask the Secretary of State for Business, Energy and Industrial Strategy, what guidance his Department has published for employers helping to meet the support needs of bereaved employees.

The Government has published several sets of guidance to help employers support the need of bereaved employees.

In 2014, the Department for Business, Innovation and Skills commissioned the Advisory, Conciliation and Arbitration Service (Acas) to publish guidance on how to manage bereavement in the workplace. The guidance was first published in 2014 and last updated in May 2018 (https://archive.acas.org.uk/media/4114/Managing-bereavement-in-the-workplace---a-good-practice-guide/pdf/Managing-bereavement-in-the-workplace-a-good-practice-guide.pdf).

Earlier this year, the Department introduced this year a new entitlement to Bereavement Leave and Pay for employees who lost a child. Guidance was published on GOV.UK in April 2020 to help employers managing this new policy (https://www.gov.uk/employers-parental-bereavement-pay-leave).

Paul Scully
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
12th Oct 2020
What assessment he has made of the potential effect of the end of the transition period on (a) further and (b) higher education.

The department is considering all aspects of how exiting the EU might affect further and higher education. This includes consideration of participation in EU-funded programmes, future arrangements for migration and for access to student finance support. We are committed to ensuring the country is prepared for every eventuality.

My officials also regularly engage with sector stakeholders on a range of issues, including leaving the EU and the Transition Period.

Michelle Donelan
Minister of State (Education)
29th Jan 2021
To ask the Secretary of State for Environment, Food and Rural Affairs, with reference to circumstances where EU REACH applies, whether UK-based companies purchasing or supplying chemicals to (a) the UK and (b) the EU will be required to access the information on each chemical they use from the original company or carry out duplicate testing if that information is not available.

Under European Union Registration, Evaluation, Authorisation and Restriction of Chemicals (EU REACH), data is owned by individual businesses and industry consortia. Great Britain (GB) companies who do not own the data they need to support their REACH registration will need to negotiate access to it from existing data owners. Industry has some time to make these arrangements. This is because we have put in place provisions for the deadlines for the full submission of data to underpin registration dossiers to be staggered, according to the quantity and hazard profile of a substance, over a period of 2, 4 or 6 years from 28 October 2021.

The UK has been at the forefront of opposing animal tests where alternative approaches could be used. Under UK REACH, registrants will submit their testing proposals to the Health and Safety Executive (HSE), who can reject them if they contain unnecessary tests on animals. We will encourage the HSE to accept duplicate submissions where possible, recognising the validity of any animal testing that has already been undertaken.

GB is now considered a third country for EU REACH purposes. GB-based EU REACH registrants wanting to maintain access to the EU market needed to transfer their existing registrations to an EU/EEA/NI entity organisation by 31 December 2020. Completing this process removed the need for either purchasing access to testing data or further animal testing.

For GB exporters to the EU that have not completed this process, registration obligations fall to the European Union/European Economic Area/Northern Ireland (EU/EEA/NI) based importer of a substance. It is possible for a GB manufacturer to appoint an Only Representative to fulfil this function and either submit a new registration if one does not exist, or pay existing EU based EU REACH registrants for a letter of access to their data and/or member status of their registration.

Rebecca Pow
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
19th Jan 2021
To ask the Secretary of State for Environment, Food and Rural Affairs, what plans his Department has to ensure that the use of animal testing is (a) minimised and (b) not duplicated following the UK’s departure from membership of the European Chemical Agency.

We will recognise the validity of any animal tests on products that have already been undertaken and so avoid the need for further testing.


The grandfathering of all existing GB-held REACH registrations into the domestic system will further avoid the need to duplicate animal testing associated with re-registration.


The UK has been at the forefront of opposing animal tests where alternative approaches could be used. This is known as the "last-resort principle", which we will retain and enshrine in legislation through our landmark Environment Bill


We are determined that there should be no need for any additional animal testing for a chemical that has already been registered, unless it is subject to further evaluation that shows the registration dossier is inadequate or there are still concerns about the hazards and risks of the chemical, especially to human health.

Rebecca Pow
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
18th Jan 2021
To ask the Secretary of State for Environment, Food and Rural Affairs, what plans his Department has obtain data from REACH on previously tested chemicals.

On 1 January, legislation to bring EU REACH into UK law came into force. This means that businesses wishing to sell or distribute chemicals domestically now need to comply with UK REACH as part of our domestic chemicals regulatory framework


UK REACH retains the fundamental approach and core principles of EU REACH, including the core principle of “no data no market”. This means that businesses that wish to access the GB market will need to supply relevant data to the Health and Safety Executive in order to support the registration of a substance.

Under EU REACH, data is owned by individual businesses and industry consortia. For GB businesses who do not own the data they need, obtaining it is a matter of commercial negotiation between themselves and the businesses that do hold that information. Industry has some time to make these arrangements. This is because we have put in place provisions for the deadlines for the full submission of data to underpin registration dossiers to be staggered, according to the quantity and hazard profile of a substance, over a period of 2, 4 or 6 years from 28 October 2021.

Rebecca Pow
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
18th Jan 2021
To ask the Secretary of State for Environment, Food and Rural Affairs, whether his Department has plans to create a separate UK chemical database as a result of the UK’s departure from the membership of the European Chemical Agency.

On the 1 January, legislation to bring EU REACH into UK law came into force. This means that businesses wishing to sell or distribute chemicals domestically now need to comply with UK REACH as part of our domestic chemicals regulatory framework


UK REACH retains the fundamental approach and core principles of EU REACH, including the core principle of “no data no market”. This means that businesses that wish to access the GB market will need to supply relevant data to the Health and Safety Executive in order to support the registration of a substance.

Under EU REACH, data is owned by individual businesses and industry consortia. For GB businesses who do not own the data they need, obtaining it is a matter of commercial negotiation between themselves and the businesses that do hold that information. Industry has some time to make these arrangements. This is because we have put in place provisions for the deadlines for the full submission of data to underpin registration dossiers to be staggered, according to the quantity and hazard profile of a substance, over a period of 2, 4 or 6 years from 28 October 2021.

Rebecca Pow
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
14th Dec 2020
To ask the Secretary of State for Environment, Food and Rural Affairs, pursuant to the Answer of 9 June 2020 to Question 54850 on Wine: Imports, what assessment he has made of the (a) financial and (b) other costs for (a) EU wine exporters, (b) UK wine importers and (c) UK wine consumers of the introduction at the end of the transition period of full VI-1 import certificates for wine imported into the UK from the EU.

The Government has not conducted an assessment of the financial or other costs of introducing VI-1 import certificates for wine imported into the UK from the EU at the end of the transition period.

The Government recognises that businesses need time to make the necessary adaptations to meet the requirement for import certification on wine imported to Great Britain from the EU and we are therefore legislating to delay the introduction until 1 July 2021.

Defra officials are working closely with UK industry to ensure we have the capability to meet the equivalent EU requirement being introduced on 1 January 2021.

Victoria Prentis
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
8th Jun 2020
To ask the Secretary of State for Environment, Food and Rural Affairs, when the UK scampi market is planned to re-open as part of the easing of covid-19 lockdown restrictions.

Up to April this year, retail sales of scampi are, year on year, up in 2020. Noticeably higher sales in March may reflect consumers buying frozen products to prepare for Covid-19-related movement restrictions. Reduced demand from the UK food service sector and export markets has had a notable impact on the Nephrops market. Whilst there are some small signs of recovery as EU Nephrops markets reopen, prices remain subdued. Defra continues to work with the seafood industry across the UK, and with the Devolved Administrations and Seafish, to monitor the impact of Covid-19 on trade, and to support the sector through these challenging times.

That support includes providing £10 million of funding to the sector in England through the Fisheries Response Fund and the Domestic Seafood Supply Scheme. The Fisheries Response Fund, worth £9 million, has provided grants of up to £10,000 for eligible catching and aquaculture businesses to help cover fixed-costs. The £1 million Domestic Seafood Supply Scheme is supporting projects to help develop the infrastructure necessary to get fish from the catching & processing sectors to consumers, creating new opportunities and improving market resilience.

Victoria Prentis
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
9th Jun 2020
To ask the Secretary of State for International Development, what recent steps her Department has taken to help support the Occupied Palestinian Territories' response to the covid-19 pandemic.

The UN assesses that although the current number of detected cases remains relatively low in Gaza and the West Bank, the capacity of the Palestinian health system to cope with an increase in COVID-19 cases is poor, including the low availability of PPE and ventilators. The situation is particularly severe in Gaza, where the health system has shortages in specialised staff, drugs and equipment.

The UK has pledged £764 million to support the global humanitarian response to COVID-19. We have delivered additional vital support in the Occupied Palestinian Territories by providing funding to the World Health Organization and UNICEF to purchase and co-ordinate the delivery of medical equipment, treat critical care patients, train frontline public health personnel and scale up laboratory testing capacity. I also recently announced £20 million in new funding, which will help the Palestinian Authority support its health workers who have been on the frontline battling coronavirus.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
9th Jun 2020
To ask the Secretary of State for International Development, what recent assessment her Department has made of the capacity of Gaza’s health system to respond effectively to the covid-19 pandemic.

The UN assesses that although the current number of detected cases remains relatively low in Gaza and the West Bank, the capacity of the Palestinian health system to cope with an increase in COVID-19 cases is poor, including the low availability of PPE and ventilators. The situation is particularly severe in Gaza, where the health system has shortages in specialised staff, drugs and equipment.

The UK has pledged £764 million to support the global humanitarian response to COVID-19. We have delivered additional vital support in the Occupied Palestinian Territories by providing funding to the World Health Organization and UNICEF to purchase and co-ordinate the delivery of medical equipment, treat critical care patients, train frontline public health personnel and scale up laboratory testing capacity. I also recently announced £20 million in new funding, which will help the Palestinian Authority support its health workers who have been on the frontline battling coronavirus.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
9th Jun 2020
To ask the Secretary of State for International Development, what recent assessment her Department has made of the availability of (a) testing kits, (b) personal protective equipment and (c) hygiene supplies necessary to contain the covid-19 pandemic in Gaza.

The UN assesses that although the current number of detected cases remains relatively low in Gaza and the West Bank, the capacity of the Palestinian health system to cope with an increase in COVID-19 cases is poor, including the low availability of PPE and ventilators. The situation is particularly severe in Gaza, where the health system has shortages in specialised staff, drugs and equipment.

The UK has pledged £764 million to support the global humanitarian response to COVID-19. We have delivered additional vital support in the Occupied Palestinian Territories by providing funding to the World Health Organization and UNICEF to purchase and co-ordinate the delivery of medical equipment, treat critical care patients, train frontline public health personnel and scale up laboratory testing capacity. I also recently announced £20 million in new funding, which will help the Palestinian Authority support its health workers who have been on the frontline battling coronavirus.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
9th Jun 2020
To ask the Secretary of State for International Development, what recent steps her Department has taken to help prevent the spread of covid-19 in the Occupied Palestinian Territories.

The UN assesses that although the current number of detected cases remains relatively low in Gaza and the West Bank, the capacity of the Palestinian health system to cope with an increase in COVID-19 cases is poor, including the low availability of PPE and ventilators. The situation is particularly severe in Gaza, where the health system has shortages in specialised staff, drugs and equipment.

The UK has pledged £764 million to support the global humanitarian response to COVID-19. We have delivered additional vital support in the Occupied Palestinian Territories by providing funding to the World Health Organization and UNICEF to purchase and co-ordinate the delivery of medical equipment, treat critical care patients, train frontline public health personnel and scale up laboratory testing capacity. I also recently announced £20 million in new funding, which will help the Palestinian Authority support its health workers who have been on the frontline battling coronavirus.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
28th Aug 2020
To ask the Secretary of State for International Trade, if her Department will work with the Scottish Chambers of Commerce Network to ensure that the 25 per cent tariff imposed by the US on exports of Single Malt Scotch Whisky and Whisky liqueurs is removed.

The Government takes the negative impact of US tariffs on Scotch Whisky very seriously. These tariffs are unnecessary, unhelpful and harm industry and consumers on both sides of the Atlantic.

The Department for International Trade engages regularly with Scottish industries which are unfairly impacted by the tariffs. On 13 August I held calls with the Scotch Whisky Association, Walkers Shortbread, Diageo and others, to update them on the outcome of the US August tariff review and to better understand their concerns.

The UK continues to lobby the US for the settlement of the Airbus/Boeing disputes and the removal of tariffs.

Greg Hands
Minister of State (Department for International Trade)
11th Feb 2021
To ask the Secretary of State for Transport, what steps the Government (a) is undertaking internationally and (b) will take at COP26 to achieve net zero-emission aviation by 2050.

The Government recognises that international action is essential given the global nature of both the aviation sector and of climate change. The UK therefore takes a leading role in the work of the International Civil Aviation Organization (ICAO) to reduce emissions from international aviation. For example, we are committed to implementing the Carbon Offsetting and Reduction Scheme for International Aviation (CORSIA) and negotiating for ICAO to agree a long-term emissions reduction goal for international aviation by its 41st Assembly in 2022.

Our COP26 presidency provides the UK with a unique opportunity to increase global ambition to decarbonise all sectors, including aviation. The government is working to deliver an ambitious set of initiatives that increase global ambition on aviation decarbonisation, showcase the latest in innovation and technology, and encourage the use of sustainable aviation fuels.

In addition, we are taking strides domestically to ensure aviation plays its part in delivering the UK’s net zero commitments: we recently established the Jet Zero Council to bring the sector together to drive decarbonisation and will shortly publish a consultation on how the sector can reach net zero.

Robert Courts
Parliamentary Under-Secretary (Department for Transport)
15th Dec 2020
To ask the Secretary of State for Transport, what engagement his Department of Transport has had with the aerospace industry to identify measures that could (a) safely open up aviation and (b) increase consumer confidence in the context of the covid-19 outbreak.

The Government is working closely with the UK’s aerospace and aviation industries, including at sector level through the Aerospace Growth Partnership.

In addition, the Global Travel Taskforce has undertaken extensive engagement with the transport industry, including aviation and aerospace, and are putting in place a range of measures to support a safe and sustainable return to air travel and encourage consumer confidence.

On 15 December we introduced the ‘Test to Release for International Travel’ scheme in England, allowing arrivals from countries not on the travel corridors list to pay for a privately provided Covid-19 test and reduce their period of self-isolation if the test is negative.

Robert Courts
Parliamentary Under-Secretary (Department for Transport)
15th Dec 2020
To ask the Secretary of State for Transport, when the Global Travel Taskforce is next scheduled to convene to discuss the outstanding recommendations from that Taskforce’s report of 24 November 2020.

The Global Travel Taskforce has concluded its work. However, the Government is working closely and at pace with industry and our international partners to implement the taskforce recommendations and ensure a safe and sustainable return to international travel.

The taskforce recommendations addressed three priorities: implementing effective public health measures; encouraging safe growth in demand; and driving a co-ordinated response with global partners.

As a first step, on 15 December the Government introduced the ‘Test to Release for International Travel’ scheme in England, allowing arrivals to pay for a privately provided Covid-19 test and reduce their required period of self-isolation if the test is negative.

Robert Courts
Parliamentary Under-Secretary (Department for Transport)
15th Dec 2020
To ask the Secretary of State for Transport, which commercial aviation routes are being prioritised as part of the plan to restart aviation following the covid-19 outbreak.

The Government recognises the challenging times facing the aviation sector?as a result of?COVID-19 and is committed to tackling this virus while enabling a sustainable and responsible return to travel.

Commercial air transport routes are a matter for airlines, and therefore decisions on how soon to operate a route after a period of inactivity is a matter for those airlines.

Since 10 July under the Travel Corridor policy, passengers arriving from a number of countries and territories are no longer required to self-isolate on arrival unless they have visited or transited through a non-exempt country or territory. Ministerial decisions on Travel Corridors are informed by risk assessments provided by the Joint Biosecurity Centre, working closely with Public Health England, using a methodology endorsed by the 4 Chief Medical Officers of the UK.

As a further measure in support of travel, the Test to Release scheme was launched on 15 December. This provides passengers arriving in England with the option to shorten the self-isolation period by up to half following a negative COVID-19 test.

Robert Courts
Parliamentary Under-Secretary (Department for Transport)
15th Dec 2020
To ask the Secretary of State for Transport, what steps he is planning to take to support the aerospace sector under his Department's Aviation Recovery Plan.

The Covid pandemic, and the need for the Government to respond to it, have clearly impacted the aviation and aerospace sectors.

The Government has therefore announced through the Global Travel Taskforce, a number of measures to assist the sector to restart over the winter period. This includes the ‘Test To Release for international travel’ (TTR) scheme, which was launched on 15 December and will boost consumer confidence in air travel.

Following the successful implementation of these measures, the government will then put forward its strategic framework for the medium and long term recovery of the aviation sector.

Robert Courts
Parliamentary Under-Secretary (Department for Transport)
26th May 2021
To ask the Secretary of State for Work and Pensions, what assessment she has made of the effect of the waiting time before new universal credit claimants are eligible for Support for Mortgage Interest on (a) debt levels and (b) mortgage defaults.

No assessment has been made on the effect of the waiting time of debt levels and mortgage defaults for new UC claimants.

Guy Opperman
Parliamentary Under-Secretary (Department for Work and Pensions)
26th May 2021
To ask the Secretary of State for Work and Pensions, what assessment he has made of the potential merits of switching to Support for Mortgage Interest rather than housing support for homeowners with a mortgage in receipt of universal credit.

No assessment has been made of the potential merits of switching to Support for Mortgage Interest rather than housing support for homeowners with a mortgage in receipt of universal credit.

Guy Opperman
Parliamentary Under-Secretary (Department for Work and Pensions)
2nd Jul 2020
To ask the Secretary of State for Work and Pensions, with reference to the Citizens Basic Income Feasibility Study Steering Group report entitled Assessing the Feasibility of Citizens' Basic Income Pilots in Scotland, if she will meet with Scottish Government officials to discuss that report and its recommendations.

I do not intend to meet with the Scottish Government officials to discuss the report on the feasibility of piloting a Citizens Basic Income (CBI) in Scotland as I do not think a CBI is the right approach for the UK. A CBI does not take any account of people’s needs and circumstances, is not targeted at the poorest in society and would be hugely expensive.

This government believes Universal Credit is the right strategy for the UK because it simplifies the benefits system, promotes and incentivises work and provides targeted support to those in most need in a way that is affordable.

Will Quince
Parliamentary Under-Secretary (Department for Work and Pensions)
2nd Jul 2020
To ask the Secretary of State for Work and Pensions, with reference to the Citizens Basic Income Feasibility Study Steering Group's report entitled Assessing the Feasibility of Citizens' Basic Income Pilots in Scotland, if she will hold discussions with (a) the Scottish Government and (b) HMRC on the potential merits of a universal basic Income pilot in Scotland.

I do not intend to meet with the Scottish Government officials to discuss the report on the feasibility of piloting a Citizens Basic Income (CBI) in Scotland as I do not think a CBI is the right approach for the UK. A CBI does not take any account of people’s needs and circumstances, is not targeted at the poorest in society and would be hugely expensive.

This government believes Universal Credit is the right strategy for the UK because it simplifies the benefits system, promotes and incentivises work and provides targeted support to those in most need in a way that is affordable.

Will Quince
Parliamentary Under-Secretary (Department for Work and Pensions)
24th Jun 2020
To ask the Secretary of State for Work and Pensions, what work her Department has undertaken to determine the feasibility of implementing a model of universal basic income throughout the UK.

No work has been undertaken. Universal Basic Income is extremely expensive, reduces work incentives and does not target those most in need of support.

Will Quince
Parliamentary Under-Secretary (Department for Work and Pensions)
27th May 2021
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of whether clinically extremely vulnerable children under 16 should be able to access covid-19 vaccines; and how many clinically extremely vulnerable children are still shielding because they do not have access to that vaccine.

Children under 16 years of age, even if they are clinically extremely vulnerable (CEV), are at low risk of serious morbidity and mortality from COVID-19. There is also a lack of safety and efficacy data for COVID-19 vaccines in children. Most children under the age of 16, including those who are CEV, are therefore not recommended for routine vaccination.

Given the very high risk of exposure to infection and outbreaks in residential settings, vaccination may be appropriate for those with severe neuro-disabilities who require frequent care in these settings. This option should be discussed between parents or guardians and the child’s clinician.

As of 1 April, due to low prevalence, shielding advice has been paused for all clinically extremely vulnerable people, including children and young people. All CEV pupils should attend their school unless they are one of the very small number of pupils under paediatric or other specialist care and have been advised by their GP or clinician not to attend. Pupils who live with someone who is CEV should continue to attend school as normal.

More information on children and COVID-19 vaccination can be found at the following link: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/984310/Greenbook_chapter_14a_7May2021.pdf

Current guidance to individuals who are clinically extremely vulnerable, including children, can be found at the following link: https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19

Nadhim Zahawi
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
20th May 2021
To ask the Secretary of State for Health and Social Care, when his Department plans to publish the Government’s Vaccine Strategy.

England’s national vaccine strategy is being refreshed to include new developments from the COVID-19 vaccine programme and the extended National Health Service flu programme. The vaccine strategy will be published in due course.

Nadhim Zahawi
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
20th May 2021
To ask the Secretary of State for Health and Social Care, what plans his Department has to implement a long-term study of immune responses in individuals vaccinated against covid-19.

The Department is funding several studies of immune responses to COVID-19 including the SARS-CoV-2 Immunity and Reinfection EvaluatioN (SIREN) study in health care workers; the Vivaldi study in care home residents and workers; and the COVID-19 Infection Survey led by the Office for National Statistics of repeat household visits looking at those who have antibodies to COVID-19, either from vaccination or previous infection.

The National Institute for Health Research’s Health Protection Research Unit in Respiratory Infections is also looking at the size and longevity of the immune response and Public Health England is monitoring antibody levels in individuals who have received either the Pfizer or Oxford/AstraZeneca vaccine.

Edward Argar
Minister of State (Department of Health and Social Care)
14th Apr 2021
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2020 to Question 56022, what plans his Department has to recover and restart recruitment to breast cancer clinical trials.

The Department’s National Institute for Health Research (NIHR) is supporting the National Health Service to deliver clinical research through the Clinical Research Network (CRN).

The NIHR’s CRN reports that of the 92 breast cancer clinical trials that it was supporting on 21 May 2020, 36 or 39% were paused as a result of the COVID-19 pandemic. As of 15 April 2021, 30 or 83% of these paused breast cancer trials have restarted and 30 new breast cancer trials have entered the portfolio since 21 May 2020.

To enable clinical research studies that have been paused to restart and recruit successfully, including breast cancer trials, plans are being developed to manage the delivery of non-COVID-19 studies to ensure successful recovery of the portfolio. Details of these plans will be published shortly.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
25th Mar 2021
To ask the Secretary of State for Health and Social Care, when he plans to publish further details on the right of referral to research as part of the NHS Long-Term Plan.

The right of referral to research is one action aimed at increasing participation in research. NHS England and NHS Improvement have indicated that this work has been delayed and they are looking to consider it further as they work with other partners, including the Department, to develop the England specific action plan that will underpin the vision. Increasing participation in research is a key strand of the national vision for clinical research published on 23 March, The Future of UK Clinical Research Delivery, which is available at the following link:

https://www.gov.uk/government/publications/the-future-of-uk-clinical-research-delivery

Edward Argar
Minister of State (Department of Health and Social Care)
24th Mar 2021
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2020 to Question 56022 on Breast Cancer: Clinical Trials, what proportion of breast cancer clinical trials have restarted in England since June 2020.

The Department’s National Institute for Health Research Clinical Research Network reports that of the 92 breast cancer clinical trials it was supporting on 21 May 2020, 36 or 39% were paused as a result of the COVID-19 pandemic. As of 26 March 2021, 30 or 83% of these paused breast cancer trials have restarted and 25 new breast cancer trials have entered the portfolio since 21 May 2020.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
24th Mar 2021
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2020 to Question 56022 on Breast Cancer: Clinical Trials, what proportion of breast cancer clinical trials have been paused in England as a result of the covid-19 outbreak since June 2020.

The Department’s National Institute for Health Research Clinical Research Network reports that of the 92 breast cancer clinical trials it was supporting on 21 May 2020, 36 or 39% were paused as a result of the COVID-19 pandemic. As of 26 March 2021, 30 or 83% of these paused breast cancer trials have restarted and 25 new breast cancer trials have entered the portfolio since 21 May 2020.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
8th Mar 2021
To ask the Secretary of State for Health and Social Care, with reference to the guidance, entitled Ventilation of indoor spaces to stop the spread of coronavirus, updated by Public Health England on 4 March 2021, whether the Government plans to revise the guidance on the use of personal protective equipment by health and care staff to require the use of FFP3 masks in all settings.

The United Kingdom-wide Infection Prevention Control (IPC) Cell has recently reviewed the evidence in relation to the transmission route for COVID-19 and the IPC precautions required. The IPC guidance was updated most recently on 21 January and the Cell agreed that no changes to the current personal protective equipment requirements were needed.

There is also consensus across the UK Chief Medical Officers that existing guidance regarding the use of face masks and FFP3 masks by healthcare workers is correct.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
1st Mar 2021
To ask the Secretary of State for Health and Social Care, what discussions Public Health England has had with the Health and Safety Executive on development of its guidance on personal protective equipment for healthcare workers.

Public Health England discusses the personal protective equipment (PPE) guidance for healthcare workers with the Health and Safety Executive and other committee members as part of the decision making committee for PPE, chaired by Department. Advice has been sought from and agreed with the Health and Safety Executive in relation to type and specification for PPE required during the pandemic. These discussions are fed back to the UK-wide Infection Prevention Control Cell, who develop the PPE guidance for healthcare workers.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
24th Feb 2021
To ask the Secretary of State for Health and Social Care, what plans he has for a review of healthcare personal protective equipment guidelines in response to the greater infectiousness of the B117 covid-19 variant.

Following the identification of new COVID-19 variants, the United Kingdom Infection Prevention Control Cell conducted a comprehensive review of available evidence to inform any necessary changes to the guidance for health workers in England including recommended levels of personal protective equipment (PPE). Based on the evidence, they concluded that current guidance and PPE recommendations remain appropriate. Emerging evidence and data on variant strains will be continually monitored and reviewed and the guidance amended accordingly if needed.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
19th Feb 2021
To ask the Secretary of State for Health and Social Care, if he will extend the Cancer Recovery Plan beyond March 2021.

There are no plans to extend the Cancer Recovery Plan.

From March, local systems will be expected to carry out local plans formed as part of the Cancer Services Recovery Plan and continue the progress that has already been made.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
19th Feb 2021
To ask the Secretary of State for Health and Social Care, what proportion of the additional £1 billion allocated in the 2020 November Spending Review to tackle waiting lists will be allocated to tackling the cancer backlog.

Arrangements for distributing the £1 billion funding, announced in the recent Spending Review, are still under consideration as the National Health Service continues to work through the current COVID-19 surge. In addition, the review also confirmed that there will be £325 million of new investment in NHS diagnostics equipment to improve clinical outcomes.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
19th Feb 2021
To ask the Secretary of State for Health and Social Care, what assessment he has made of the (a) adequacy of access for multiple sclerosis (MS) patients to healthcare professional support during the covid-19 outbreak and (b) potential merits of oral therapy options that can make treatment more convenient for MS patients.

No specific assessment has been made. Throughout the COVID-19 pandemic, the NHS in England has maintained access to urgent and emergency care, including for patients with multiple sclerosis (MS). For non-urgent care, providers have been rolling out remote consultations using video, telephone, email and text message services as a priority where appropriate.

The National Institute for Health and Care Excellence guideline Multiple sclerosis in adults: management, updated November 2019, sets out best practice for clinicians in the treatment of MS, which includes guidance on the usage of oral and intravenous treatments for patients with relapse remitting MS.

Edward Argar
Minister of State (Department of Health and Social Care)
19th Feb 2021
To ask the Secretary of State for Health and Social Care, what proportion of the additional £260 million allocated to Health Education England in the November 2020 Spending Review will be allocated to the cancer workforce.

Full details on funding allocations towards National Health Service workforce budgets, including relating to the cancer workforce, in 2021-22 are subject to a detailed financial planning exercise and will be finalised in due course.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
19th Feb 2021
To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies of the Scottish Medicine Consortium’s decision to approve ozanimod for people with active relapsing remitting multiple sclerosis (RRMS); and what plans he has for MS patients in other parts of the UK having the same access to new oral treatment options.

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing evidence-based guidance for the National Health Service in England on whether medicines represent a clinical and cost-effective use of resources.

NICE is currently developing guidance for the NHS in England on the use of ozanimod for treating relapsing remitting multiple sclerosis. NICE recently consulted stakeholders on its initial draft recommendations on ozanimod and NICE will carefully consider the comments received in developing its final recommendations.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
19th Feb 2021
To ask the Secretary of State for Health and Social Care, what assessment he has made of whether the ability of multiple sclerosis (MS) patients to access to treatment options has been adversely affected during the covid-19 outbreak; and what plans he has to ensure that MS patients are able to access treatment that is appropriate for (a) their disease course, (b) overall quality of life and (c) other individual needs.

No specific assessment has been made. Throughout the COVID-19 pandemic, the National Health Service in England has maintained access to urgent and emergency care, including treatments for patients with multiple sclerosis (MS). For non-urgent care, remote consultations using video, telephone, email and text message services have been made available as a priority where appropriate.

On 23 December 2020, NHS England and NHS Improvement outlined priorities for the remainder of 2020-2021 and into 2021-2022, including maximising the NHS’s capacity to treat non-COVID-19 patients. This capacity includes services for people with neurological conditions, including for MS treatments across their disease course, whether they are for their overall quality of life or other individual needs - for example, physiotherapy, occupational therapy, and speech and language therapy.

Edward Argar
Minister of State (Department of Health and Social Care)
4th Feb 2021
To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of staff working in elderly care homes in England; and how many of those staff have had a covid-19 vaccine.

The vaccination strategy, published on 13 January 2021, estimated that there are 0.4 million staff working in care homes for older adults in England.

We are working with the vaccination programme in NHS England to monitor progress on the vaccination of care home staff. NHS England now publish weekly data on the vaccination of care home staff, which is available at the following link:

https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/

Nadhim Zahawi
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
4th Feb 2021
To ask the Secretary of State for Health and Social Care, how many people live in elderly care homes in England; and how many of those people have had the covid-19 vaccine to date.

Statistics on the total number of residents and the number vaccinated in elderly care home residents are available at the following link:

https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/

Nadhim Zahawi
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
8th Jan 2021
To ask the Secretary of State for Health and Social Care, what proportion of adult care home residents received the first dose of a covid-19 vaccine by 3 January 2021.

Data on the proportion of adult care home residents who have received the first dose of their vaccine by 3 January 2021 is not available. This data has been published since 4 February 2021.

NHS England publishes weekly data on the vaccination of residents and staff in older adult care homes which is available at the following link:

https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/

Nadhim Zahawi
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
24th Nov 2020
To ask the Secretary of State for Health and Social Care, what plans he has to commit to achieving 90 per cent HPV vaccination coverage by 2030 as set out in the World Health Organisation’s Global Strategy to Accelerate the Elimination of Cervical Cancer.

NHS England and NHS Improvement are working closely with Public Health England and the Department to drive improvements in immunisation uptake and coverage in all routine childhood immunisations. The Department intends to publish a vaccination strategy in the near future to maintain and develop the United Kingdom’s immunisation programme.

The human papillomavirus (HPV) vaccination is routinely administered in schools, with a target of 90% coverage for 13 to 14 year old females. Where full HPV coverage has not been attained in schools, HPV vaccination can be administered in general practice up to the age of 25 to support high levels of population coverage. A review of vaccination and immunisations in 2019 has led to reformed general practice contractual arrangements to support the delivery of vaccination activity to increase coverage. In addition, all practices are required to have a named vaccination lead, to support maximisation of uptake.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
11th Nov 2020
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with specialist bereavement organisations on the formal and informal support that bereaved employees need in the workplace.

We are taking a cross-Government approach to address bereavement support and help ensure that families and friends of those deceased get the support they need – particularly during this difficult time. We are engaging with specialist bereavement organisations to assess how we can support them in doing their important work, which includes providing support to bereaved employees.

Nadine Dorries
Minister of State (Department of Health and Social Care)
8th Sep 2020
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 July 2020 to Question 73784 on clinical negligence, if his Department will work with healthcare, regulatory and legal experts to establish a new, independent, expert advisory committee to oversee claims, complaints and litigation including criminal prosecution against doctors as a result of the covid-19 outbreak.

We are committed to ensuring National Health Service staff have the support and resources they need to respond to the pandemic. We established the Clinical Negligence Scheme for Coronavirus to handle pandemic claims not falling under existing state indemnity schemes and we communicated these plans in a letter of 2 April to NHS staff and providers. We have also taken steps, working with the NHS, professional regulators and across Government to ensure that claims, complaints and court processes can appropriately take into account the unprecedented context NHS staff are working within in response to COVID-19.

We have no plans to establish alternative arrangements to oversee claims, complaints and litigation against doctors as a result of the response to COVID-19.

Nadine Dorries
Minister of State (Department of Health and Social Care)
8th Sep 2020
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 July 2020 to Question 73784 on clinical negligence, whether the Government is developing a cross-departmental approach to agreeing how claims, complaints and litigation against doctors and healthcare professionals resulting from the covid-19 outbreak are managed.

We are committed to ensuring National Health Service staff have the support and resources they need to respond to the pandemic. We established the Clinical Negligence Scheme for Coronavirus to handle pandemic claims not falling under existing state indemnity schemes and we communicated these plans in a letter of 2 April to NHS staff and providers. We have also taken steps, working with the NHS, professional regulators and across Government to ensure that claims, complaints and court processes can appropriately take into account the unprecedented context NHS staff are working within in response to COVID-19.

We have no plans to establish alternative arrangements to oversee claims, complaints and litigation against doctors as a result of the response to COVID-19.

Nadine Dorries
Minister of State (Department of Health and Social Care)
8th Sep 2020
To ask the Secretary of State for Health and Social Care, what his Department’s long term strategy is for tackling the increasing costs of clinical negligence cases.

The rising costs of clinical negligence are unsustainable and we are committed to tackling this issue, working with the Ministry of Justice, other Government departments and NHS Resolution. This is a complex issue and the work is ongoing. We will bring forward a publication in due course.

Nadine Dorries
Minister of State (Department of Health and Social Care)
28th Aug 2020
To ask the Secretary of State for Health and Social Care, when his Department plans to publish the social care Green Paper.

The Government’s number one priority for adult social care is for everyone who relies on care to get the care they need throughout the COVID-19 pandemic.

We are committed to bringing forward a plan for social care to ensure that everyone is treated with dignity and respect and to find long-term solutions for one of the biggest challenges we face as a society. There are complex questions to address and it is important that we give these issues our full consideration in the light of current circumstances.

Helen Whately
Minister of State (Department of Health and Social Care)
14th Jul 2020
To ask the Secretary of State for Health and Social Care, what estimate he has made of how many additional flu vaccines will be provided in the lead up to the 2020 Winter period compared to the number of such vaccines administered in 2019.

The flu vaccination programme is a crucial part of preparing the United Kingdom for winter. The vaccine is already available to those most at risk of flu, children aged 2-3, all primary school aged children and all healthcare workers. In 2019/20 over 14.6 million doses of the flu vaccine were administered to these groups.

As part of our planning for this coming winter, we are seeking to increase uptake for all the cohorts who are currently eligible for flu vaccination and extend who is eligible. Information on the ambitions for flu vaccine uptake will be published in the second annual flu letter 2020/21.

General practitioners and community pharmacists are directly responsible for ordering flu vaccine from suppliers for the adult flu programme, and advice was issued to them about ordering sufficient doses of vaccine for their patient groups.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
13th Jul 2020
To ask the Secretary of State for Health and Social Care, what plans his Department has for the recruitment of new social care staff after the implementation of the points-based immigration system in January 2021.

It is the Government’s long-term ambition to recruit more people into social care to meet the future needs of society. In the short term, in order to attract people into social care now, we launched a new national recruitment campaign, ‘Care for others; Make a difference’, which ran across broadcast, digital and social media. We have also launched a new online platform to fast-track recruitment into the adult social care sector, which will sit alongside the many local initiatives that have been put in place to recruit staff.

The new Health and Care visa will make it cheaper, quicker and easier for eligible social care professions such as social workers, occupational therapists and nurses from around the world to come to work the United Kingdom. In addition all social care workers will now be permanently exempt from paying the Immigration Health Surcharge.

Helen Whately
Minister of State (Department of Health and Social Care)
6th Jul 2020
To ask the Secretary of State for Health and Social Care, what plans are in place to restock personal protective equipment stockpiles before the end of 2020.

We are working to expand the supply of personal protective equipment (PPE) from overseas and improve domestic manufacturing capability. We are expanding and improving the logistics network for delivering to the front line.

Since 25 February we have delivered over 2.3 billion items of PPE across the health and social care system within England. Almost 30 billion items of PPE have been ordered from United Kingdom-based manufacturers and international partners to provide a continuous supply in the coming months.

We continue to model future demand for PPE to cover a range of possible scenarios, working closely with the Scientific Advisory Group for Emergencies to ensure it is underpinned by the latest science. We are confident in the stocks and sources of supply of PPE to meet the needs of health and social care over the next seven and 90 days and are increasingly looking further ahead. We have moved from an emergency situation a few months ago to a stable situation which allows us to prepare with resilience for any second spike or a new wave in the autumn or winter.

We are making sure our stockpile is ready for any future wave of the pandemic by ensuring we use lessons learnt and are informed by expert scientific advice.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
29th Jun 2020
To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of local systems and Cancer Alliances on reducing the post-covid-19 outbreak demand for cancer services.

No assessment has been made at this time.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
29th Jun 2020
To ask the Secretary of State for Health and Social Care, with reference to the letter of 29 April 2020 from the NHS Chief Executive and NHS Chief Operating Officer to the Chief executives of all NHS trusts and foundation trusts et al, what progress local systems and Cancer Alliances have made on restoring the provision of cancer (a) diagnostic and (b) surgical services to pre-covid-19 outbreak levels as recommended in that letter.

On 8 June 2020, the National Cancer Director and the National Clinical Director for Cancer issued a further letter of guidance to National Health Service cancer services on Second phase of NHS response to COVID-19 for cancer services. The letter notes that the work for local systems and Cancer Alliances to identify ring-fenced diagnostic and surgical capacity for cancer should now be well advanced, so that referrals, diagnostics and treatment can be brought back to pre-pandemic levels at the earliest opportunity to minimise potential harm, and to reduce the scale of the post-pandemic surge in demand. The new guidance is based on three key principles: capacity, fairness and confidence. Cancer Alliances should work with their regional teams to provide such services.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
29th Jun 2020
To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle regional variation in the restoration of cancer services as a result of the covid-19 outbreak.

On 8 June 2020, the National Cancer Director and the National Clinical Director for Cancer issued a further letter of guidance to National Health Service cancer services on Second phase of NHS response to COVID-19 for cancer services. The letter notes that the work for local systems and Cancer Alliances to identify ring-fenced diagnostic and surgical capacity for cancer should now be well advanced, so that referrals, diagnostics and treatment can be brought back to pre-pandemic levels at the earliest opportunity to minimise potential harm, and to reduce the scale of the post-pandemic surge in demand. The new guidance is based on three key principles: capacity, fairness and confidence. Cancer Alliances should work with their regional teams to provide such services.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
29th Jun 2020
To ask the Secretary of State for Health and Social Care, when the Government plans to publish its plans for cancer services to enable people living with cancer to receive necessary treatment and care.

On 8 June 2020, the National Cancer Director and the National Clinical Director for Cancer issued further guidance to NHS cancer services on the second phase of the NHS response to COVID-19 for cancer services. The states that the work for local systems and Cancer Alliances to identify ring-fenced diagnostic and surgical capacity for cancer should now be well advanced, so that referrals, diagnostics and treatment can be brought back to pre-pandemic levels at the earliest opportunity to minimise potential harm, and to reduce the scale of the post-pandemic surge in demand. Cancer Alliances should work with their regional teams to provide these essential services.

This includes focussing on reducing the number of over 62-day waiters on cancer pathways, particularly rescheduling diagnostic procedures or treatment for those who have had their care delayed by the pandemic.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
29th Jun 2020
To ask the Secretary of State for Health and Social Care, with reference to the letter of 29 April 2020 from the NHS Chief Executive and NHS Chief Operating Officer to the Chief executives of all NHS trusts and foundation trusts et al, if he will publish data on the extent of the backlog of cancer treatment during the period of the second phase of the NHS's response to the covid-19 outbreak.

Data on cancer referrals and treatments is collected and published by NHS England and available at the following link:

https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/

Latest data available is April 2020, data for May 2020 will be published on 9 July 2020.

The National Health Service has continued to provide urgent and emergency services throughout the outbreak and has run the ‘Open for Business’ media campaign to encourage people with potentially serious health issues, such as cancer, to continue to seek medical advice and attend essential appointments. Cancer Alliances and Cancer Hubs have identified surgical capacity to meet demand for cancer services and treatments at this time.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
24th Jun 2020
To ask the Secretary of State for Health and Social Care, if he will respond to the open letter published on by the British Medical Journal on 23 June 2020 on a potential second wave of covid-19 in the UK.

We have been clear that we will continue to be guided by the latest scientific advice and will give the National Health Service whatever it needs, as we have done throughout this unprecedented pandemic.

Thanks to the dedication of NHS staff, hospitals have not been overwhelmed and intensive care capacity continues to meet the needs of patients.

Effective local management of any outbreak is the first line of protection against a second wave. In the event the local response is not sufficient to contain outbreaks, the Government would reintroduce measures if necessary, to contain the virus and stop it spreading to the wider population.

Helen Whately
Minister of State (Department of Health and Social Care)
22nd Jun 2020
To ask the Secretary of State for Health and Social Care, how many covid-19 tests performed at home were sent to testing centres on each day from 27 April 2020 to 5 May 2020.

Using data from Royal Mail the number of home tests conducted in this time frame are shown in the following table. It should be noted that the Royal Mail’s data captures when the kit is delivered at their delivery office near the laboratory. For example, if the kit is ‘scanned as delivered’ on 4 May, it will then make it to the laboratory the following morning, 5 May, at the agreed ‘drop-off’ time.

Tests returned are counted and reported only once they have been processed by the laboratory and will appear in the data for pillar 2.

Data on the number of tests processed by pillar is available at the following link:

https://coronavirus.data.gov.uk/testing

Information on the methodology of how testing data is compiled is available at the following link:

https://www.gov.uk/government/publications/nhs-test-and-trace-statistics-england-methodology/nhs-test-and-trace-statistics-england-methodology

Date

Kits scanned as delivered

26 April 2020

954

27 April 2020

2,069

28 April 2020

2,762

29 April 2020

2,377

30 April 2020

2,966

1 May 2020

4,895

2 May 2020

5,907

3 May 2020

6,906

4 May 2020

7,110

Total

35,946

Helen Whately
Minister of State (Department of Health and Social Care)
11th Jun 2020
To ask the Secretary of State for Health and Social Care, when his Department plans to respond to Questions 43048 and 43049 tabled by the hon. member for Central Ayrshire on 4 May 2020.

I refer the hon. Member to the answer I gave to Question 43048 on 16 June.

We take parliamentary scrutiny incredibly seriously and it is fundamentally important that hon. Members are provided with accurate and timely information to enable them to hold the Government to account. We are working rapidly to provide all Members with accurate answers to their questions, as well as supporting the Government’s response to the unprecedented challenge of the COVID-19 pandemic.

The hon. Member’s Question 43049 will be answered as soon as possible.

Nadine Dorries
Minister of State (Department of Health and Social Care)
11th Jun 2020
To ask the Secretary of State for Health and Social Care, how many (a) covid-19 tests that were sent to the US for analysis require re-processing and (b) individuals that took those tests require re-testing.

66,648 test samples were sent to a laboratory in the United States of America. 38,196 were successfully completed and 28,452 were void.

We worked hard to get complete tests for people under difficult circumstances. In many cases this worked and we are grateful for the team for their efforts. In some cases, it did not and the correct judgement was made to void the tests. Everyone affected was offered a new test immediately and we worked quickly to restore full capacity in the United Kingdom.

Helen Whately
Minister of State (Department of Health and Social Care)
10th Jun 2020
To ask the Secretary of State for Health and Social Care, what representations he has received on the alleged omission of recommendations that could help protect BAME people from covid-19 from the Government's review of disparities in risks and outcomes.

Various representations were received on the alleged omission of recommendations from Public Health England’s report entitled ‘COVID-19: review of disparities in risks and outcomes’, published on 2 June 2020. No recommendations were removed.

Alongside the epidemiological review, Professor Fenton undertook a rapid evidence review and external stakeholder engagement with a significant number of individuals and organisations within the black, Asian and minority ethnic community, to hear their views, concerns and ideas about the impact of COVID-19 on their communities. The results of that work have now been published and will inform the Government’s next steps being taken forward by the Parliamentary Under-Secretary of State for Equalities (Kemi Badenoch MP).

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
9th Jun 2020
To ask the Secretary of State for Health and Social Care, how much of the personal protective equipment stockpiled as part of the preparations for the UK leaving the EU without a deal have been used during the response to the covid-19 outbreak; and by what date he estimates those stockpiles will be replenished.

The United Kingdom has been an international exemplar in preparedness and our pandemic stockpile of personal protective equipment (PPE) and vital supplies is considered a very high-quality mark in international terms. At the start of the pandemic, Public Health England already had large stockpiles of PPE as part of its ongoing contingency measures to prepare for an outbreak. There were also supplies of PPE held through the NHS Supply Chain.

The Government has massively expanded both our supply of PPE from overseas and our domestic manufacturing capability and we are confident in the stocks and sources of supply of PPE to meet the needs of health and social care staff over the next seven and 90 days.

The Government has now signed contracts for over 2 billion items of PPE through UK-based manufacturers, ensuring we build and maintain a domestic base for the future.

Jo Churchill
Parliamentary Under-Secretary (Department of Health and Social Care)
8th Jun 2020
To ask the Secretary of State for Health and Social Care, what proportion of breast cancer clinical trials have been paused in England as a result of the covid-19 outbreak.

The Department’s National Institute for Health Research (NIHR) Clinical Research Network (CRN) has information on 92 breast cancer clinical trials which it was supporting in March 2020. Half (50%) of these trials paused their recruitment as a result of the COVID-19 pandemic, 45% have continued and 5% have closed.

We have now entered a new phase of the pandemic, where the number of new cases of COVID-19 is declining so the NIHR, including the CRN, is working towards the restoration of research funded and/or supported by the NIHR - including clinical trials on breast cancer. To help initiate this process, the NIHR has developed a ‘Framework for Restart’, which provides a structure to guide the restart, while maintaining local decision-making and flexibility to respond to COVID-19. Further information is available at the following link:

https://www.nihr.ac.uk/documents/restart-framework/24886

Helen Whately
Minister of State (Department of Health and Social Care)
8th Jun 2020
To ask the Secretary of State for Health and Social Care, how many staff working in health and social care in England have died from covid-19.

As of 9 June 2020, 211 National Health Service staff deaths involving COVID-19 have been reported in England. The number of NHS worker deaths is verified from direct reports from NHS employing organisations and the number of individuals identified as deceased healthcare workers by non-NHS organisations. This information is investigated and triangulated by NHS England to give a high level of confidence of validity.

Public Health England analysis of mortality data from the Office for National Statistics (ONS) shows that at least 214 deaths involving COVID-19 among social care workers were registered 21 March to 8 May 2020 (in England, of those aged 20-64 years). The ONS will be publishing an updated figure in due course.

Helen Whately
Minister of State (Department of Health and Social Care)
4th May 2020
To ask the Secretary of State for Health and Social Care, in addition to the covid-19 tests performed at test centres, how many covid-19 tests performed at home were sent to testing centres each day from 27 April 2020 to 5 May 2020.

We introduced large-scale home testing at the end of April to make testing more accessible to individuals. Between 27 April – 5 May over 95,000 home tests were dispatched to users. In that same time period, nearly 21,000 test samples were processed by our labs. The difference in these numbers is due to the number of days between test dispatch, through to the sample being taken and then being collected by courier to be sent to the lab. This means that the 21,000 test samples processed will not correlate to tests dispatched on these dates.

Nadine Dorries
Minister of State (Department of Health and Social Care)
4th May 2020
To ask the Secretary of State for Health and Social Care, in addition to the tests performed at test centres, how many home testing kits were sent out each day from between 27 April 2020 and 5 May 2020.

Between 27 April 2020 and 5 May 2020, a total of 168,050 Home Test Kits were sent out. Between 5 May 2020 and 6 August 2020, a further 5,514,897 Home Test Kits were sent out.

Nadine Dorries
Minister of State (Department of Health and Social Care)
6th Mar 2020
To ask the Secretary of State for Health and Social Care, what discussions he has had with the General Medical Council on re-licensing of retired doctors returning to practice during the covid-19 outbreak.

Officials have been working closely with the General Medical Council (GMC) to ensure it has a plan in place to use its powers to support delivery of essential health and care services during an epidemic, if this is required. When registering professionals, the GMC Registrar has the power to add conditions that restrict the types of activities that a doctor can carry out. Additionally, any emergency registered retired doctors who are deployed, will be subject to oversight by local employing organisations to ensure the safe delivery of care.

Edward Argar
Minister of State (Department of Health and Social Care)
6th Mar 2020
To ask the Secretary of State for Health and Social Care, whether he has made arrangements to provide full Crown indemnity to (a) doctors and (b) nurses returning to clinical practice to assist during the covid-19 outbreak.

If doctors or nurses return to the National Health Service in England for the purposes of assisting with the COVID-19 outbreak and carry out work on behalf of an NHS trust or a general practitioner (GP) practice, they would be covered for clinical negligence indemnity via one of the following state indemnity schemes:

- The Clinical Negligence Scheme for Trusts, if they are engaged by an NHS trust to provide NHS services; and

- The Clinical Negligence Scheme for General Practice, if they are engaged by a GP practice to provide NHS services (i.e. a GP practice, the main business of which is the provision of primary medical services for the NHS).

Edward Argar
Minister of State (Department of Health and Social Care)
5th Feb 2020
To ask the Secretary of State for Health and Social Care, what the average waiting time was by NHS foundation trust for (a) hip replacement and (b) knee replacement surgery in 2018-19.

A full list of all trusts along with the number of hip and knee replacement procedures and the average waiting time is attached.

The data shows the number of procedures between the period April 2018 until March 2019.

It should be noted the data does not show individual patients as the same person may have been admitted into a National Health Service hospital on more than one occasion.

Edward Argar
Minister of State (Department of Health and Social Care)
20th May 2021
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment he has made of the effect of global equitable access to covid-19 vaccines on the emergence of viral variants of covid-19.

All viruses change constantly through mutation, and many thousands of variants of the virus that causes COVID-19 have been detected across the world. Most have little to no impact on the virus's ability to cause infections and disease, but some can pose higher risks. Variants are more likely to arise in areas of high transmission. In addition to basic public health measures, the World Health Organisation has advised that ensuring equitable access to COVID-19 vaccines will reduce virus circulation. This will ultimately lead to fewer mutations and variants.

The UK is committed to rapid, equitable access to safe and effective vaccines. We are among the largest donors to the COVAX Advance Market Commitment (AMC), committing £548 million, which leveraged $1 billion from other donors in 2020 through match funding. This support to COVAX has been critical to it supplying COVID-19 vaccines to over 120 countries, and economies. We have also committed to share the majority of our supply of any surplus vaccine doses with COVAX.

Wendy Morton
Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)
20th May 2021
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, how many covid-19 vaccine doses the UK has shared through the COVAX facility in 2021.

The UK remains committed to rapid, equitable access to safe and effective vaccines, and the Prime Minister has said that we will share the majority of any doses that are surplus to UK needs with COVAX. As the multilateral mechanism set up to support international cooperation on vaccines, COVAX remains best-placed for allocating vaccines where they are most needed, and will be most effective. We have already committed £548 million to the COVAX Advance Market Commitment, which specifically supports vaccine access for at least 500 million people in up to 92 low and middle income countries in 2021. Our wider support for COVAX has enabled the mechanism to reach over 120 countries.

Wendy Morton
Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)
12th May 2021
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether covid-19 vaccine dose-sharing will count towards the Official Development Assistance budget for 2021.

The UK is a founding member, and one of the largest donors to the COVAX Advance Market Commitment, contributing £548 million for global equitable access. This £548 million spend, and the vital work it supports, has been assessed as ODA eligible, and will be met under our commitment to spend 0.5% of UK GNI on ODA.

Wendy Morton
Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)
12th May 2021
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what recent discussions he has had with his international counterparts on sharing surplus covid-19 vaccine doses through the COVAX facility in 2021.

The UK is committed to rapid, equitable access to safe and effective vaccines, treatments, and tests globally. The Prime Minister, Foreign Secretary, and I continue to speak to our international counterparts, discussing the shared fight against coronavirus.

For example, at the recent G7 Foreign and Development Ministerial Meeting, we agreed a statement on Equitable Access and Collaboration that recognised COVAX as "the key mechanism for global sharing of vaccines…to enable the rapid equitable deployment of vaccines." We committed to supporting access to safe, effective vaccines, with distribution guided by principles of equity and public health data.

Wendy Morton
Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)
12th May 2021
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what plans he has to allocate additional funding to the COVAX facility in 2022.

The UK is committed to rapid equitable access to safe and effective vaccines. We are among the largest donors to the COVAX Advance Market Commitment (AMC), committing £548 million, which leveraged $1 billion from other donors through match funding in 2020. This support to COVAX has been critical in supplying COVID-19 vaccines to over 120 countries and economies. The Prime Minister has also committed to sharing the majority of any surplus vaccines with COVAX.

The UK is committed to our G7 Presidency championing equitable access to vaccines, therapeutics, and diagnostics to help the world fight COVID-19, and build back better from this pandemic. We are engaging, including with our G7 partners, on COVAX's approach for 2022, and beyond, and continue to advocate for further financial contributions to COVAX to support equitable access to COVID-19 vaccines

Wendy Morton
Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)
20th Jan 2021
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether he plans to make representations to the Government of Israel on the demolition or seizure of at least 114 EU-funded structures provided as humanitarian assistance to Palestinian communities in the West Bank.

The UK is concerned by the continued demolitions of Palestinian property and infrastructure by Israeli authorities. In all but the most exceptional of circumstances demolitions are contrary to International Humanitarian Law. The practice causes unnecessary suffering to ordinary Palestinians and is harmful to the peace process.

The UK regularly raises demolitions with the Government of Israel. I raised my concerns about demolitions of Palestinian and humanitarian structures with the Israeli Ambassador on 29 October 2020, and the UK Ambassador to Israel outlined the UK's position to the Israeli Authorities in Jerusalem on the same day. UK senior officials raised demolitions with the Israeli Ambassador to the UK on 10 November 2020. The UK also urged the Government of Israel to end demolitions of property in the West Bank at the UN Security council on 21 December 2020. UK officials from the British Consulate in Jerusalem have made regular visits to areas at risk of demolition and eviction to reiterate UK support for those communities, including to Khan al Ahmar on 20 November, Givat Hamatos on 22 October, the South Hebron Hills on 19 October, and Ras al Tin on 16 October. We are focused on preventing demolitions from happening in the first place through our legal aid programme, which supports Bedouin communities and Palestinians facing demolition or home eviction in both the West Bank and East Jerusalem. We continue to urge the Government of Israel to develop improved mechanisms for zoning, planning and permitting in Area C for the benefit of the Palestinian population, including by facilitating local Palestinian participation in such processes.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
20th Jan 2021
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps he plans to take to tackle the (a) increase in the demolition of Palestinian property and (b) subsequent displacement of 524 Palestinian children in 2020.

The UK is concerned by the continued demolitions of Palestinian property and infrastructure by Israeli authorities. In all but the most exceptional of circumstances demolitions are contrary to International Humanitarian Law. The practice causes unnecessary suffering to ordinary Palestinians and is harmful to the peace process.

The UK regularly raises demolitions with the Government of Israel. I raised my concerns about demolitions of Palestinian and humanitarian structures with the Israeli Ambassador on 29 October 2020, and the UK Ambassador to Israel outlined the UK's position to the Israeli Authorities in Jerusalem on the same day. UK senior officials raised demolitions with the Israeli Ambassador to the UK on 10 November 2020. The UK also urged the Government of Israel to end demolitions of property in the West Bank at the UN Security council on 21 December 2020. UK officials from the British Consulate in Jerusalem have made regular visits to areas at risk of demolition and eviction to reiterate UK support for those communities, including to Khan al Ahmar on 20 November, Givat Hamatos on 22 October, the South Hebron Hills on 19 October, and Ras al Tin on 16 October. We are focused on preventing demolitions from happening in the first place through our legal aid programme, which supports Bedouin communities and Palestinians facing demolition or home eviction in both the West Bank and East Jerusalem. We continue to urge the Government of Israel to develop improved mechanisms for zoning, planning and permitting in Area C for the benefit of the Palestinian population, including by facilitating local Palestinian participation in such processes.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
14th Dec 2020
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps his Department is taking to support Gaza’s healthcare system during a period of increased cases of covid-19 in the Occupied Palestinian Territories.

The UK remains concerned about the ongoing humanitarian situation in Gaza and the impact of COVID-19 on an already fragile healthcare system. Recognising the severity of the situation, we were one of the first donors to provide funding to support the health and humanitarian response to the COVID-19 pandemic in the Occupied Palestinian Territories (OPTs). We have provided £1.25 million funding (the World Health Organisation with £630,000 and the United Nations Children's Fund with £620,000) to purchase and co-ordinate delivery of medical equipment, treat critical care patients, train frontline health workers and scale up laboratory testing capacity - mainly in Gaza.

In addition, we are providing £2.5 million to the World Food Programme to provide food and cash assistance for the most vulnerable Palestinians to help alleviate the humanitarian situation. We have also contributed £1 million to the United Nations Relief and Works Agency's Emergency Appeal in the OPTs which will help provide emergency food to over one million food-insecure refugees in Gaza.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
14th Dec 2020
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what recent assessment his Department has made of the effect of the covid-19 pandemic on levels of food insecurity in Gaza.

The UK remains concerned about the ongoing humanitarian situation in Gaza, compounded by the impact of COVID-19.

We recognise the importance of tackling food insecurity. To support, we are providing £2.5 million to the World Food Programme to provide food and cash assistance to the most vulnerable Palestinians. We have also contributed £1 million to the United Nations Relief and Works Agency's Emergency Appeal in the Occupied Palestinian Territories which will help provide emergency food to over one million food-insecure refugees in Gaza.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
14th Dec 2020
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps his Department is taking to tackle the gap in oxygen supply for covid-19 patients in Gaza.

We remain concerned about the capacity of the Palestinian health system to cope with the increasing number of COVID-19 cases, especially in Gaza. We welcome the recent 30% increase in hospital beds for patients suffering critical and severe cases, and the recent procurement by World Health Organisation of two additional oxygen generators. The UK continues to monitor the situation closely.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
9th Dec 2020
To ask the Secretary of State for Foreign, Commonwealth and Development Office, pursuant to the Answer of 8 December 2020 to Question 124769 and with reference to the cessation of polymerase chain reaction covid-19 testing in Gaza on 6 December 2020, what steps his Department is taking to help support (a) testing and (b) control of covid-19 in the Gaza Strip.

We remain concerned about the capacity of the Palestinian health system to cope with the increasing number of COVID-19 cases. We are aware of the temporary cessation of COVID-19 testing in Gaza on 6th December and welcome reports from the World Health Organisation that further testing kits arrived in Gaza on 7th December and testing resumed.

We have already delivered vital support to respond to the COVID-19 outbreak in the Occupied Palestinian Territories through £1.25 million in funding (World Health Organisation with £630,000 and United Nations Children's Fund with £620,000). This funding helped to provide over 20,000 testing kits, mainly in Gaza.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
3rd Dec 2020
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what recent assessment his Department has made of the needs of people with disabilities in the occupied Palestinian territory during the covid-19 pandemic.

Disability inclusion is an important issue for the FCDO, and the Ministerial team remains committed to embedding it across all our work, including as we respond to the ongoing impact of COVID-19.

The UK is committed to supporting people with disabilities across our programmes in the OPTs. Following the outbreak of COVID-19, we have approved additional programming to strengthen disability inclusion across Palestinian society, which aims to ensure people with disabilities (PwD) are accounted for in the COVID-19 crisis response through reviewing laws, regulations, HR policies and bylaws in public sector to analyse barriers to PwDs' participation in decision making. This will be followed by an advocacy campaign targeting the gaps identified in the analysis. We also engage frequently with the Israelis on issues affecting ordinary Palestinians, including the impact of COVID-19.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
3rd Dec 2020
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what recent steps his Department has taken to support the protection and fulfilment of the rights of people with disabilities in the occupied Palestinian territory throughout the covid-19 outbreak.

Disability inclusion is an important issue for the FCDO, and the Ministerial team remains committed to embedding it across all our work, including as we respond to the ongoing impact of COVID-19.

The UK is committed to supporting people with disabilities across our programmes in the OPTs. Following the outbreak of COVID-19, we have approved additional programming to strengthen disability inclusion across Palestinian society, which aims to ensure people with disabilities (PwD) are accounted for in the COVID-19 crisis response through reviewing laws, regulations, HR policies and bylaws in public sector to analyse barriers to PwDs' participation in decision making. This will be followed by an advocacy campaign targeting the gaps identified in the analysis. We also engage frequently with the Israelis on issues affecting ordinary Palestinians, including the impact of COVID-19.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
3rd Dec 2020
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what recent steps he has taken to encourage Israel to uphold its obligations to ensure the respect and fulfilment of the rights of Palestinians with disabilities under its effective control in the occupied Palestinian territory.

Disability inclusion is an important issue for the FCDO, and the Ministerial team remains committed to embedding it across all our work, including as we respond to the ongoing impact of COVID-19.

The UK is committed to supporting people with disabilities across our programmes in the OPTs. Following the outbreak of COVID-19, we have approved additional programming to strengthen disability inclusion across Palestinian society, which aims to ensure people with disabilities (PwD) are accounted for in the COVID-19 crisis response through reviewing laws, regulations, HR policies and bylaws in public sector to analyse barriers to PwDs' participation in decision making. This will be followed by an advocacy campaign targeting the gaps identified in the analysis. We also engage frequently with the Israelis on issues affecting ordinary Palestinians, including the impact of COVID-19.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
25th Nov 2020
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, with reference to the Answer of 15 June 2020 to Question 57229 on Gaza, what assessment his Department has made of the recent warning from the World Health Organization that within a week the health system in Gaza will be unable to care for critical cases of covid-19.

The UK remains concerned about the capacity of an already fragile health system in Gaza. We have provided £1.25 million funding (WHO with £630,000 and UNICEF with £620,000) to purchase and co-ordinate delivery of medical equipment, treat critical care patients, train frontline health workers and scale up laboratory testing capacity – mainly in Gaza. This funding helped to provide over 20,000 testing kits, 59,500 PPE items for around 4,900 health workers.

The British Consulate General also supported the delivery of 24 respirators to the Palestinian Ministry of Health for several hospitals across the West Bank and Gaza to help provide support for critical cases.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
25th Nov 2020
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, pursuant to the Answer of 15 June 2020 to Question 57229 on Gaza, what recent assessment his Department has made of the capacity of the health system in Gaza to cope with the rapid increase in covid-19 cases.

The UK remains concerned about the capacity of an already fragile health system in Gaza. We have provided £1.25 million funding (WHO with £630,000 and UNICEF with £620,000) to purchase and co-ordinate delivery of medical equipment, treat critical care patients, train frontline health workers and scale up laboratory testing capacity – mainly in Gaza. This funding helped to provide over 20,000 testing kits, 59,500 PPE items for around 4,900 health workers.

The British Consulate General also supported the delivery of 24 respirators to the Palestinian Ministry of Health for several hospitals across the West Bank and Gaza to help provide support for critical cases.

James Cleverly
Minister of State (Foreign, Commonwealth and Development Office)
24th Nov 2020
To ask the Chancellor of the Exchequer, whether his Department has made an assessment of the potential merits of establishing a Government-backed equity fund to help the recapitalisation of supply chain companies in the (a) aerospace and (b) wider manufacturing sector.

The Government is committed to supporting businesses access the finance they need to achieve their full growth potential. For some companies, further debt may not be the right answer, and the private sector should be the first port of call for any business seeking new equity investment.

The aerospace sector and its aviation customers are being supported with over £9 billion support through the Bank of England’s Covid Corporate Financing Facility, grants for research and development, loan guarantees and support for aerospace exports.

The manufacturing sector has been well supported in its ability to access finance through the government loan schemes throughout the current pandemic period. Manufacturing firms have had over 7,000 CBILS loans worth over £2bn and over 74,000 BBLS loans worth over £2.3bn, bringing the total amount received through CBILS and BBLS to £4.4bn to over 80,000 manufacturing firms. These figures indicate that manufacturing firms have received a higher proportion of lending through the schemes relative to their share of the UK SME business population.

The Government will keep policy under review, and rigorously test any proposals for their value for money.

Kemi Badenoch
Exchequer Secretary (HM Treasury)
16th Nov 2020
To ask the Chancellor of the Exchequer, what recent discussions he has had with the Secretary of State for Health and Social Care on the adequacy of financial support for people working in social care during the covid-19 outbreak.

The Chancellor and the Health Secretary have discussed a wide range of health-related issues during the COVID-19 pandemic.

In September, we announced the extension of the Infection Control Fund until March 2021, bringing the total funding for infection control measures in social care to over £1.1 billion. This funding can be used to financially support staff in line with the grant conditions. This includes paying staff who are isolating, in line with government guidance, their normal wages while doing so.

Steve Barclay
Chief Secretary to the Treasury
16th Oct 2020
To ask the Chancellor of the Exchequer, whether he plans to extend the VAT holiday on personal protective equipment after 31 October 2020, in response to the ongoing covid-19 outbreak.

The temporary zero rate of VAT on Personal Protective Equipment (PPE) was an extraordinary measure to help affected sectors during the initial shock of the COVID-19 pandemic, when the global supply of PPE did not meet demand. This measure will come to an end on 31 October, as new measures introduced by the Government will ensure supply of COVID-related PPE to affected sectors from 1 November.

Jesse Norman
Financial Secretary (HM Treasury)
17th Jul 2020
To ask the Chancellor of the Exchequer, whether employers can keep workers on the Coronavirus Job Retention Scheme until the end of October 2020 whose fixed-term contracts are due to end in November 2020.

The Government has ensured that the Coronavirus Job Retention Scheme (CJRS) is available for as many people as possible. Hence, employees can be on any type of contract and be eligible to be furloughed under the CJRS.

From August 2020, the level of the grant will be tapered slowly to reflect that people will be returning to work. An employer can continue to claim for all employees furloughed for 21 days before 30 June as long as any single claim period does not exceed the maximum number of employees they claimed for under any claim before 30 June.

Further information on eligibility for the CJRS can be found at https://www.gov.uk/guidance/check-which-employees-you-can-put-on-furlough-to-use-the-coronavirus-job-retention-scheme.

Jesse Norman
Financial Secretary (HM Treasury)
9th Jul 2020
To ask the Chancellor of the Exchequer, what estimate his Department the number of (a) people and (b) businesses not eligible for any of the Government's financial support packages during the covid-19 outbreak.

The Government has provided a comprehensive economic response that is one of the most generous globally, taking unprecedented steps to support families, businesses and the most vulnerable. As well as the Coronavirus Job Retention Scheme (CJRS) and Self-Employment Income Support Scheme (SEISS), this package includes a suite of government-backed loans and grants to businesses, tax deferrals, rental support and mortgage and consumer credit holidays.

This comprehensive package also includes extra funding for the welfare safety net, to get us through the outbreak and help those unable to access other forms of support. The temporary welfare measures include increases to Universal Credit and Local Housing Allowance, a relaxation of the Universal Credit minimum income floor and making Statutory Sick Pay easier to access. We have also announced above £300bn of guaranteed loans for supporting businesses to access finance through The Coronavirus Business Interruption Loan Scheme, and the Coronavirus Corporate Financing Facility and the Coronavirus Large Business Interruption Loan Scheme (CLBILS). On 27 April, we also announced the new Bounce Back Loans Scheme, which will ensure that the smallest businesses can access up to £50,000 loans in a matter of just days

Now, as outlined in the Summer Economic Update, our Plan for Jobs will support, protect and create jobs. This plan will make available up to £30 billion to help kickstart the nation’s economic recovery ahead of a fuller package of medium-term recovery measures in the upcoming Autumn Budget and Spending Review.

Kemi Badenoch
Exchequer Secretary (HM Treasury)
8th Jul 2020
To ask the Chancellor of the Exchequer, what steps he is taking to increase eligibility for (a) people and (b) business not eligible for the Government's financial support measures during the covid-19 outbreak.

The Government has provided a comprehensive economic response that is one of the most generous of its kind in the world, taking unprecedented steps to support families, businesses and the most vulnerable. As well as the Coronavirus Job Retention Scheme (CJRS) and Self-Employment Income Support Scheme (SEISS), this package includes Government-backed loans and grants to businesses, tax deferrals, rental support and mortgage and consumer credit holidays.

This package also includes extra funding for the welfare safety net to help those through this outbreak who are unable to access other forms of support. The temporary welfare measures include increases to Universal Credit and Local Housing Allowance, a relaxation of the Universal Credit minimum income floor, and making Statutory Sick Pay easier to access.

Now, the Government’s new Plan for Jobs will support, protect and create jobs. This plan will make available up to £30 billion to help kickstart the nation’s economic recovery ahead of a fuller package of medium-term recovery measures in the forthcoming Autumn Budget and Spending Review.

Jesse Norman
Financial Secretary (HM Treasury)
4th May 2020
To ask the Chancellor of the Exchequer, with reference to his Department's news story entitled, Chancellor sets out extra £750 million coronavirus funding for frontline charities, published on 8 April 2020, what Barnett consequentials will accrue to the Scottish Government in relation to financial support for hospices in Scotland.

The UK government is applying the Barnett formula in the normal way to the additional funding for charities announced by the Chancellor, with the Scottish Government receiving at least £55 million in Barnett consequentials in relation to the £750 million package.

Funding for charities is a devolved matter and it is for the Scottish Government to decide how to support charities in Scotland.

Steve Barclay
Chief Secretary to the Treasury